Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,330.00p on 05-05-2026 at 18:30:06
Change -182.00p -1.35%
Buy 13,398.00p
Sell 13,394.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 0.00 at 13,423.04449p
Day's Volume: 3,363,807
Last Close: 13,330.00p
Open: 13,564.00p
ISIN: GB0009895292
Day's Range 13,276.00p - 13,566.00p
52wk Range: 9,651.00p - 15,730.00p
Market Capitalisation: £206.73b
VWAP: 13,411.59262p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 13,423.04449p SI Trade
Currency Conversion
 19:01:37 - 05-May-26
Unknown* 0 13,410.4754p SI Trade
Currency Conversion
 18:57:08 - 05-May-26
Unknown* 0 13,403.82118p SI Trade
Currency Conversion
 18:51:33 - 05-May-26
Unknown* 0 13,406.77861p SI Trade
Currency Conversion
 18:48:52 - 05-May-26
Unknown* 0 13,410.4754p SI Trade
Currency Conversion
 18:45:54 - 05-May-26
Unknown* 0 13,398.64568p SI Trade
Currency Conversion
 18:43:03 - 05-May-26
Unknown* 0 13,409.73605p SI Trade
Currency Conversion
 18:37:23 - 05-May-26
Unknown* 1 13,376.83462p Currency Conversion
Negotiated Trade
OTC Trade
 18:27:59 - 05-May-26
Unknown* 0 13,380.90108p SI Trade
Currency Conversion
 18:27:14 - 05-May-26
Unknown* 12 13,380.90108p SI Trade
Currency Conversion
 18:27:10 - 05-May-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
5th May 2026 (Tue) 13,564.00 13,566.00 13,276.00 13,330.00 3,363,807
4th May 2026 (Mon) 13,512.00 13,512.00 13,512.00 13,512.00 0
1st May 2026 (Fri) 13,810.00 13,810.00 13,512.00 13,512.00 1,580,341
30th Apr 2026 (Thu) 13,782.00 14,070.00 13,706.00 13,948.00 2,819,765
29th Apr 2026 (Wed) 13,816.00 13,910.00 13,488.00 13,692.00 2,414,183
28th Apr 2026 (Tue) 13,862.00 13,930.00 13,688.00 13,900.00 2,124,265
27th Apr 2026 (Mon) 14,026.00 14,072.00 13,864.00 13,972.00 2,157,259
24th Apr 2026 (Fri) 14,310.00 14,310.00 13,948.00 13,956.00 2,456,514
23rd Apr 2026 (Thu) 14,380.00 14,556.00 14,348.00 14,492.00 2,131,626
22nd Apr 2026 (Wed) 14,534.00 14,640.00 14,484.00 14,536.00 1,456,287
21st Apr 2026 (Tue) 14,740.00 14,894.00 14,494.00 14,560.00 1,917,122
20th Apr 2026 (Mon) 15,076.00 15,108.00 14,882.00 14,952.00 1,172,933
17th Apr 2026 (Fri) 14,736.00 15,118.00 14,736.00 15,118.00 2,867,650
16th Apr 2026 (Thu) 14,822.00 14,912.00 14,706.00 14,862.00 1,350,676
15th Apr 2026 (Wed) 15,084.00 15,120.00 14,766.00 14,766.00 2,164,561
14th Apr 2026 (Tue) 15,022.00 15,032.00 14,894.00 14,918.00 1,317,948
13th Apr 2026 (Mon) 15,044.00 15,130.00 14,924.00 14,988.00 1,950,720
10th Apr 2026 (Fri) 15,272.00 15,448.00 15,230.00 15,230.00 2,342,279
9th Apr 2026 (Thu) 15,282.00 15,288.00 15,048.00 15,276.00 2,693,782
8th Apr 2026 (Wed) 15,334.00 15,444.00 15,194.00 15,216.00 2,754,215
7th Apr 2026 (Tue) 15,190.00 15,282.00 14,868.00 14,958.00 2,103,198
6th Apr 2026 (Mon) 15,316.00 15,316.00 15,316.00 15,316.00 0
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
1st May 2026 3:00 pm RNS Total Voting Rights and Admission of Shares
1st May 2026 7:05 am RNS FDA ODAC vote on camizestrant in breast cancer
1st May 2026 7:00 am RNS FDA ODAC recommends Truqap in prostate cancer
29th Apr 2026 7:00 am RNS 1st Quarter Results
28th Apr 2026 7:00 am RNS Breztri approved in the US for asthma
27th Apr 2026 7:00 am RNS Saphnelo self-administration approved in the US
23rd Apr 2026 7:00 am RNS Directorate change
21st Apr 2026 7:00 am RNS I CAN PhIII interim analysis met primary endpoint
20th Apr 2026 7:00 am RNS Third tozorakimab positive Phase III in COPD
9th Apr 2026 5:15 pm RNS Result of AGM
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: Citi cuts Severn Trent and United Utilities

5th May 2026 09:35

(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday: Read More

LONDON MARKET CLOSE: Oil price declines amid reports of new Iran offer

1st May 2026 17:05

(Alliance News) - The FTSE 100 closed down on Friday, but above early lows, while the oil price fell amid reports that Iran has made a new proposal amid stalled US peace talks. Read More

Mixed outcome for AstraZeneca as US committee votes on cancer drugs

1st May 2026 09:03

(Alliance News) - AstraZeneca PLC on Friday said it had secured a recommendation for its cancer drug Truqap from US authorities, but failed to secure a majority in favour of its treatment camizestrant. Read More

IN BRIEF: AstraZeneca gets FDA panel nod for Truqap in prostate cancer

1st May 2026 01:24

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Says the US Food & Drug Administration's Oncologic Drugs Advisory Committee recommended the benefit–risk profile of Truqap when used with abiraterone and hormone‑lowering therapy for PTen‑deficient metastatic hormone‑sensitive prostate cancer. AstraZeneca says the recommendation follows late‑stage trial results showing the combination helps delay disease progression. The company adds it is the first targeted treatment to show benefit in this form of the disease and notes the decision follows the FDA's earlier acceptance of its application. Truqap is a targeted treatment designed to block a growth pathway used by cancer cells. Read More

LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking

30th Apr 2026 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,219.11
Change-144.82

Login to your account

Forgot Password?

Not Registered